Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today ann... Devices, Interventional, Cardiology, Product Launch Medtronic, Resolute Onyx, Drug-Eluting Stent
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news